Nathan Weinstein
Stock Analyst at Aegis Capital
(0.21)
# 3,272
Out of 4,413 analysts
56
Total ratings
14.06%
Success rate
-26.18%
Average return
Main Sectors:
30 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVGN Evogene | Maintains: Buy | $10 → $8 | $0.72 | +1,017.94% | 2 | Sep 12, 2022 | |
| DRIO DarioHealth | Maintains: Buy | $20 → $15 | $1.46 | +927.40% | 6 | Aug 18, 2022 | |
| VNRX VolitionRx | Maintains: Buy | $9 → $6 | $0.87 | +592.84% | 5 | Aug 15, 2022 | |
| IMUX Immunic | Maintains: Buy | $40 → $35 | $1.30 | +2,592.31% | 2 | Aug 8, 2022 | |
| STXS Stereotaxis | Initiates: Buy | $6 | $2.41 | +148.96% | 1 | Jul 12, 2022 | |
| AUVI Applied UV | Initiates: Buy | $1,000 | $0.58 | +173,813.04% | 1 | Jun 27, 2022 | |
| ORMP Oramed Pharmaceuticals | Maintains: Buy | $35 → $30 | $2.34 | +1,182.05% | 4 | May 16, 2022 | |
| TRVI Trevi Therapeutics | Initiates: Buy | $10 | $2.86 | +249.65% | 1 | Mar 29, 2022 | |
| MDWD MediWound | Maintains: Buy | $63 → $49 | $19.27 | +154.28% | 2 | Mar 21, 2022 | |
| ENVB Enveric Biosciences | Downgrades: Hold | $350 → $10 | $0.93 | +975.27% | 2 | Mar 8, 2022 | |
| CING Cingulate | Initiates: Buy | $180 | $1.04 | +17,207.69% | 1 | Jan 11, 2022 | |
| CMMB Chemomab Therapeutics | Initiates: Buy | n/a | $0.73 | - | 1 | Dec 7, 2021 | |
| AVGR Avinger | Maintains: Buy | n/a | $3.68 | - | 2 | Nov 15, 2021 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | n/a | $1.94 | - | 2 | Nov 1, 2021 | |
| KTRA Kintara Therapeutics | Maintains: Buy | n/a | $0.15 | - | 3 | Sep 30, 2021 | |
| CDTX Cidara Therapeutics | Maintains: Buy | $180 → $160 | $11.81 | +1,254.78% | 2 | Sep 22, 2021 | |
| XOMA XOMA Corporation | Maintains: Buy | n/a | $25.82 | - | 2 | Sep 9, 2021 | |
| ATAI Atai Life Sciences | Maintains: Buy | n/a | $2.05 | - | 3 | Aug 17, 2021 | |
| SCYX SCYNEXIS | Maintains: Buy | n/a | $1.72 | - | 2 | Jun 7, 2021 | |
| ENTX Entera Bio | Initiates: Buy | n/a | $2.00 | - | 1 | Mar 22, 2021 | |
| CWBR CohBar | Initiates: Buy | n/a | $0.86 | - | 1 | Mar 15, 2021 | |
| GLSI Greenwich LifeSciences | Initiates: Buy | n/a | $14.00 | - | 1 | Jan 26, 2021 | |
| VTGN VistaGen Therapeutics | Initiates: Buy | n/a | $4.74 | - | 1 | Oct 8, 2020 | |
| DYNT Dynatronics | Maintains: Buy | n/a | $0.50 | - | 1 | Sep 29, 2020 | |
| ACST Acasti Pharma | Downgrades: Hold | n/a | $2.85 | - | 2 | Sep 2, 2020 | |
| BMRA Biomerica | Initiates: Buy | n/a | $0.63 | - | 1 | Aug 21, 2020 | |
| ICCC ImmuCell | Initiates: Buy | n/a | $5.00 | - | 1 | Jul 13, 2020 | |
| AMRN Amarin Corporation | Maintains: Buy | n/a | $0.84 | - | 1 | May 4, 2020 | |
| EKSO Ekso Bionics Holdings | Maintains: Buy | n/a | $1.28 | - | 1 | Apr 13, 2020 | |
| ANIX Anixa Biosciences | Initiates: Buy | n/a | $3.09 | - | 1 | Mar 23, 2020 |
Evogene
Sep 12, 2022
Maintains: Buy
Price Target: $10 → $8
Current: $0.72
Upside: +1,017.94%
DarioHealth
Aug 18, 2022
Maintains: Buy
Price Target: $20 → $15
Current: $1.46
Upside: +927.40%
VolitionRx
Aug 15, 2022
Maintains: Buy
Price Target: $9 → $6
Current: $0.87
Upside: +592.84%
Immunic
Aug 8, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $1.30
Upside: +2,592.31%
Stereotaxis
Jul 12, 2022
Initiates: Buy
Price Target: $6
Current: $2.41
Upside: +148.96%
Applied UV
Jun 27, 2022
Initiates: Buy
Price Target: $1,000
Current: $0.58
Upside: +173,813.04%
Oramed Pharmaceuticals
May 16, 2022
Maintains: Buy
Price Target: $35 → $30
Current: $2.34
Upside: +1,182.05%
Trevi Therapeutics
Mar 29, 2022
Initiates: Buy
Price Target: $10
Current: $2.86
Upside: +249.65%
MediWound
Mar 21, 2022
Maintains: Buy
Price Target: $63 → $49
Current: $19.27
Upside: +154.28%
Enveric Biosciences
Mar 8, 2022
Downgrades: Hold
Price Target: $350 → $10
Current: $0.93
Upside: +975.27%
Cingulate
Jan 11, 2022
Initiates: Buy
Price Target: $180
Current: $1.04
Upside: +17,207.69%
Chemomab Therapeutics
Dec 7, 2021
Initiates: Buy
Price Target: n/a
Current: $0.73
Upside: -
Avinger
Nov 15, 2021
Maintains: Buy
Price Target: n/a
Current: $3.68
Upside: -
Inspira Technologies Oxy B.H.N.
Nov 1, 2021
Maintains: Buy
Price Target: n/a
Current: $1.94
Upside: -
Kintara Therapeutics
Sep 30, 2021
Maintains: Buy
Price Target: n/a
Current: $0.15
Upside: -
Cidara Therapeutics
Sep 22, 2021
Maintains: Buy
Price Target: $180 → $160
Current: $11.81
Upside: +1,254.78%
XOMA Corporation
Sep 9, 2021
Maintains: Buy
Price Target: n/a
Current: $25.82
Upside: -
Atai Life Sciences
Aug 17, 2021
Maintains: Buy
Price Target: n/a
Current: $2.05
Upside: -
SCYNEXIS
Jun 7, 2021
Maintains: Buy
Price Target: n/a
Current: $1.72
Upside: -
Entera Bio
Mar 22, 2021
Initiates: Buy
Price Target: n/a
Current: $2.00
Upside: -
CohBar
Mar 15, 2021
Initiates: Buy
Price Target: n/a
Current: $0.86
Upside: -
Greenwich LifeSciences
Jan 26, 2021
Initiates: Buy
Price Target: n/a
Current: $14.00
Upside: -
VistaGen Therapeutics
Oct 8, 2020
Initiates: Buy
Price Target: n/a
Current: $4.74
Upside: -
Dynatronics
Sep 29, 2020
Maintains: Buy
Price Target: n/a
Current: $0.50
Upside: -
Acasti Pharma
Sep 2, 2020
Downgrades: Hold
Price Target: n/a
Current: $2.85
Upside: -
Biomerica
Aug 21, 2020
Initiates: Buy
Price Target: n/a
Current: $0.63
Upside: -
ImmuCell
Jul 13, 2020
Initiates: Buy
Price Target: n/a
Current: $5.00
Upside: -
Amarin Corporation
May 4, 2020
Maintains: Buy
Price Target: n/a
Current: $0.84
Upside: -
Ekso Bionics Holdings
Apr 13, 2020
Maintains: Buy
Price Target: n/a
Current: $1.28
Upside: -
Anixa Biosciences
Mar 23, 2020
Initiates: Buy
Price Target: n/a
Current: $3.09
Upside: -